Global Biosimilar Market Insight and Forecast to 2026
The research team projects that the Biosimilar market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Allergan plc
Dr. Reddy’s Laboratories
BioXpress Therapeutics
BIOCAD
Coherus BioSciences
Biocon
Intas Pharmaceuticals Limited
Celltrion
Boehringer Ingelheim
Genor BioPharma
Novartis
Pfizer
Reliance Life Sciences
By Type
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
By Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biosimilar 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biosimilar Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biosimilar Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilar market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Allergan plc
Dr. Reddy’s Laboratories
BioXpress Therapeutics
BIOCAD
Coherus BioSciences
Biocon
Intas Pharmaceuticals Limited
Celltrion
Boehringer Ingelheim
Genor BioPharma
Novartis
Pfizer
Reliance Life Sciences
By Type
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
By Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biosimilar 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biosimilar Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biosimilar Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilar market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilar Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilar Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Growth Hormones
1.4.3 Monoclonal Antibodies
1.4.4 Insulin
1.4.5 Peptides
1.4.6 Erythropoietin
1.4.7 Others
1.5 Market by Application
1.5.1 Global Biosimilar Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Chronic and Autoimmune Diseases
1.5.4 Growth Hormone Deficiency
1.5.5 Infectious Diseases
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biosimilar Market Perspective (2021-2026)
2.2 Biosimilar Growth Trends by Regions
2.2.1 Biosimilar Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biosimilar Historic Market Size by Regions (2015-2020)
2.2.3 Biosimilar Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biosimilar Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biosimilar Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biosimilar Average Price by Manufacturers (2015-2020)
4 BIOSIMILAR PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biosimilar Market Size (2015-2026)
4.1.2 Biosimilar Key Players in North America (2015-2020)
4.1.3 North America Biosimilar Market Size by Type (2015-2020)
4.1.4 North America Biosimilar Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biosimilar Market Size (2015-2026)
4.2.2 Biosimilar Key Players in East Asia (2015-2020)
4.2.3 East Asia Biosimilar Market Size by Type (2015-2020)
4.2.4 East Asia Biosimilar Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biosimilar Market Size (2015-2026)
4.3.2 Biosimilar Key Players in Europe (2015-2020)
4.3.3 Europe Biosimilar Market Size by Type (2015-2020)
4.3.4 Europe Biosimilar Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biosimilar Market Size (2015-2026)
4.4.2 Biosimilar Key Players in South Asia (2015-2020)
4.4.3 South Asia Biosimilar Market Size by Type (2015-2020)
4.4.4 South Asia Biosimilar Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biosimilar Market Size (2015-2026)
4.5.2 Biosimilar Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biosimilar Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biosimilar Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biosimilar Market Size (2015-2026)
4.6.2 Biosimilar Key Players in Middle East (2015-2020)
4.6.3 Middle East Biosimilar Market Size by Type (2015-2020)
4.6.4 Middle East Biosimilar Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biosimilar Market Size (2015-2026)
4.7.2 Biosimilar Key Players in Africa (2015-2020)
4.7.3 Africa Biosimilar Market Size by Type (2015-2020)
4.7.4 Africa Biosimilar Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biosimilar Market Size (2015-2026)
4.8.2 Biosimilar Key Players in Oceania (2015-2020)
4.8.3 Oceania Biosimilar Market Size by Type (2015-2020)
4.8.4 Oceania Biosimilar Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biosimilar Market Size (2015-2026)
4.9.2 Biosimilar Key Players in South America (2015-2020)
4.9.3 South America Biosimilar Market Size by Type (2015-2020)
4.9.4 South America Biosimilar Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biosimilar Market Size (2015-2026)
4.10.2 Biosimilar Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biosimilar Market Size by Type (2015-2020)
4.10.4 Rest of the World Biosimilar Market Size by Application (2015-2020)
5 BIOSIMILAR CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biosimilar Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biosimilar Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biosimilar Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biosimilar Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biosimilar Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biosimilar Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biosimilar Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biosimilar Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biosimilar Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biosimilar Consumption by Countries
5.10.2 Kazakhstan
6 BIOSIMILAR SALES MARKET BY TYPE (2015-2026)
6.1 Global Biosimilar Historic Market Size by Type (2015-2020)
6.2 Global Biosimilar Forecasted Market Size by Type (2021-2026)
7 BIOSIMILAR CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biosimilar Historic Market Size by Application (2015-2020)
7.2 Global Biosimilar Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOSIMILAR BUSINESS
8.1 Allergan plc
8.1.1 Allergan plc Company Profile
8.1.2 Allergan plc Biosimilar Product Specification
8.1.3 Allergan plc Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Dr. Reddy’s Laboratories
8.2.1 Dr. Reddy’s Laboratories Company Profile
8.2.2 Dr. Reddy’s Laboratories Biosimilar Product Specification
8.2.3 Dr. Reddy’s Laboratories Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 BioXpress Therapeutics
8.3.1 BioXpress Therapeutics Company Profile
8.3.2 BioXpress Therapeutics Biosimilar Product Specification
8.3.3 BioXpress Therapeutics Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 BIOCAD
8.4.1 BIOCAD Company Profile
8.4.2 BIOCAD Biosimilar Product Specification
8.4.3 BIOCAD Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Coherus BioSciences
8.5.1 Coherus BioSciences Company Profile
8.5.2 Coherus BioSciences Biosimilar Product Specification
8.5.3 Coherus BioSciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Biocon
8.6.1 Biocon Company Profile
8.6.2 Biocon Biosimilar Product Specification
8.6.3 Biocon Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Intas Pharmaceuticals Limited
8.7.1 Intas Pharmaceuticals Limited Company Profile
8.7.2 Intas Pharmaceuticals Limited Biosimilar Product Specification
8.7.3 Intas Pharmaceuticals Limited Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Celltrion
8.8.1 Celltrion Company Profile
8.8.2 Celltrion Biosimilar Product Specification
8.8.3 Celltrion Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Boehringer Ingelheim
8.9.1 Boehringer Ingelheim Company Profile
8.9.2 Boehringer Ingelheim Biosimilar Product Specification
8.9.3 Boehringer Ingelheim Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Genor BioPharma
8.10.1 Genor BioPharma Company Profile
8.10.2 Genor BioPharma Biosimilar Product Specification
8.10.3 Genor BioPharma Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Novartis
8.11.1 Novartis Company Profile
8.11.2 Novartis Biosimilar Product Specification
8.11.3 Novartis Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Pfizer
8.12.1 Pfizer Company Profile
8.12.2 Pfizer Biosimilar Product Specification
8.12.3 Pfizer Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Reliance Life Sciences
8.13.1 Reliance Life Sciences Company Profile
8.13.2 Reliance Life Sciences Biosimilar Product Specification
8.13.3 Reliance Life Sciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biosimilar (2021-2026)
9.2 Global Forecasted Revenue of Biosimilar (2021-2026)
9.3 Global Forecasted Price of Biosimilar (2015-2026)
9.4 Global Forecasted Production of Biosimilar by Region (2021-2026)
9.4.1 North America Biosimilar Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biosimilar Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biosimilar Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biosimilar Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biosimilar Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biosimilar Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biosimilar Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biosimilar Production, Revenue Forecast (2021-2026)
9.4.9 South America Biosimilar Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biosimilar Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biosimilar by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biosimilar by Country
10.2 East Asia Market Forecasted Consumption of Biosimilar by Country
10.3 Europe Market Forecasted Consumption of Biosimilar by Countriy
10.4 South Asia Forecasted Consumption of Biosimilar by Country
10.5 Southeast Asia Forecasted Consumption of Biosimilar by Country
10.6 Middle East Forecasted Consumption of Biosimilar by Country
10.7 Africa Forecasted Consumption of Biosimilar by Country
10.8 Oceania Forecasted Consumption of Biosimilar by Country
10.9 South America Forecasted Consumption of Biosimilar by Country
10.10 Rest of the world Forecasted Consumption of Biosimilar by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biosimilar Distributors List
11.3 Biosimilar Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biosimilar Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilar Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilar Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Growth Hormones
1.4.3 Monoclonal Antibodies
1.4.4 Insulin
1.4.5 Peptides
1.4.6 Erythropoietin
1.4.7 Others
1.5 Market by Application
1.5.1 Global Biosimilar Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Chronic and Autoimmune Diseases
1.5.4 Growth Hormone Deficiency
1.5.5 Infectious Diseases
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biosimilar Market Perspective (2021-2026)
2.2 Biosimilar Growth Trends by Regions
2.2.1 Biosimilar Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biosimilar Historic Market Size by Regions (2015-2020)
2.2.3 Biosimilar Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biosimilar Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biosimilar Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biosimilar Average Price by Manufacturers (2015-2020)
4 BIOSIMILAR PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biosimilar Market Size (2015-2026)
4.1.2 Biosimilar Key Players in North America (2015-2020)
4.1.3 North America Biosimilar Market Size by Type (2015-2020)
4.1.4 North America Biosimilar Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biosimilar Market Size (2015-2026)
4.2.2 Biosimilar Key Players in East Asia (2015-2020)
4.2.3 East Asia Biosimilar Market Size by Type (2015-2020)
4.2.4 East Asia Biosimilar Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biosimilar Market Size (2015-2026)
4.3.2 Biosimilar Key Players in Europe (2015-2020)
4.3.3 Europe Biosimilar Market Size by Type (2015-2020)
4.3.4 Europe Biosimilar Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biosimilar Market Size (2015-2026)
4.4.2 Biosimilar Key Players in South Asia (2015-2020)
4.4.3 South Asia Biosimilar Market Size by Type (2015-2020)
4.4.4 South Asia Biosimilar Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biosimilar Market Size (2015-2026)
4.5.2 Biosimilar Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biosimilar Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biosimilar Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biosimilar Market Size (2015-2026)
4.6.2 Biosimilar Key Players in Middle East (2015-2020)
4.6.3 Middle East Biosimilar Market Size by Type (2015-2020)
4.6.4 Middle East Biosimilar Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biosimilar Market Size (2015-2026)
4.7.2 Biosimilar Key Players in Africa (2015-2020)
4.7.3 Africa Biosimilar Market Size by Type (2015-2020)
4.7.4 Africa Biosimilar Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biosimilar Market Size (2015-2026)
4.8.2 Biosimilar Key Players in Oceania (2015-2020)
4.8.3 Oceania Biosimilar Market Size by Type (2015-2020)
4.8.4 Oceania Biosimilar Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biosimilar Market Size (2015-2026)
4.9.2 Biosimilar Key Players in South America (2015-2020)
4.9.3 South America Biosimilar Market Size by Type (2015-2020)
4.9.4 South America Biosimilar Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biosimilar Market Size (2015-2026)
4.10.2 Biosimilar Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biosimilar Market Size by Type (2015-2020)
4.10.4 Rest of the World Biosimilar Market Size by Application (2015-2020)
5 BIOSIMILAR CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biosimilar Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biosimilar Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biosimilar Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biosimilar Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biosimilar Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biosimilar Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biosimilar Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biosimilar Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biosimilar Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biosimilar Consumption by Countries
5.10.2 Kazakhstan
6 BIOSIMILAR SALES MARKET BY TYPE (2015-2026)
6.1 Global Biosimilar Historic Market Size by Type (2015-2020)
6.2 Global Biosimilar Forecasted Market Size by Type (2021-2026)
7 BIOSIMILAR CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biosimilar Historic Market Size by Application (2015-2020)
7.2 Global Biosimilar Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOSIMILAR BUSINESS
8.1 Allergan plc
8.1.1 Allergan plc Company Profile
8.1.2 Allergan plc Biosimilar Product Specification
8.1.3 Allergan plc Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Dr. Reddy’s Laboratories
8.2.1 Dr. Reddy’s Laboratories Company Profile
8.2.2 Dr. Reddy’s Laboratories Biosimilar Product Specification
8.2.3 Dr. Reddy’s Laboratories Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 BioXpress Therapeutics
8.3.1 BioXpress Therapeutics Company Profile
8.3.2 BioXpress Therapeutics Biosimilar Product Specification
8.3.3 BioXpress Therapeutics Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 BIOCAD
8.4.1 BIOCAD Company Profile
8.4.2 BIOCAD Biosimilar Product Specification
8.4.3 BIOCAD Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Coherus BioSciences
8.5.1 Coherus BioSciences Company Profile
8.5.2 Coherus BioSciences Biosimilar Product Specification
8.5.3 Coherus BioSciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Biocon
8.6.1 Biocon Company Profile
8.6.2 Biocon Biosimilar Product Specification
8.6.3 Biocon Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Intas Pharmaceuticals Limited
8.7.1 Intas Pharmaceuticals Limited Company Profile
8.7.2 Intas Pharmaceuticals Limited Biosimilar Product Specification
8.7.3 Intas Pharmaceuticals Limited Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Celltrion
8.8.1 Celltrion Company Profile
8.8.2 Celltrion Biosimilar Product Specification
8.8.3 Celltrion Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Boehringer Ingelheim
8.9.1 Boehringer Ingelheim Company Profile
8.9.2 Boehringer Ingelheim Biosimilar Product Specification
8.9.3 Boehringer Ingelheim Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Genor BioPharma
8.10.1 Genor BioPharma Company Profile
8.10.2 Genor BioPharma Biosimilar Product Specification
8.10.3 Genor BioPharma Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Novartis
8.11.1 Novartis Company Profile
8.11.2 Novartis Biosimilar Product Specification
8.11.3 Novartis Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Pfizer
8.12.1 Pfizer Company Profile
8.12.2 Pfizer Biosimilar Product Specification
8.12.3 Pfizer Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Reliance Life Sciences
8.13.1 Reliance Life Sciences Company Profile
8.13.2 Reliance Life Sciences Biosimilar Product Specification
8.13.3 Reliance Life Sciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biosimilar (2021-2026)
9.2 Global Forecasted Revenue of Biosimilar (2021-2026)
9.3 Global Forecasted Price of Biosimilar (2015-2026)
9.4 Global Forecasted Production of Biosimilar by Region (2021-2026)
9.4.1 North America Biosimilar Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biosimilar Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biosimilar Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biosimilar Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biosimilar Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biosimilar Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biosimilar Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biosimilar Production, Revenue Forecast (2021-2026)
9.4.9 South America Biosimilar Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biosimilar Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biosimilar by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biosimilar by Country
10.2 East Asia Market Forecasted Consumption of Biosimilar by Country
10.3 Europe Market Forecasted Consumption of Biosimilar by Countriy
10.4 South Asia Forecasted Consumption of Biosimilar by Country
10.5 Southeast Asia Forecasted Consumption of Biosimilar by Country
10.6 Middle East Forecasted Consumption of Biosimilar by Country
10.7 Africa Forecasted Consumption of Biosimilar by Country
10.8 Oceania Forecasted Consumption of Biosimilar by Country
10.9 South America Forecasted Consumption of Biosimilar by Country
10.10 Rest of the world Forecasted Consumption of Biosimilar by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biosimilar Distributors List
11.3 Biosimilar Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biosimilar Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Biosimilar Market Share by Type: 2020 VS 2026
Table 2. Human Growth Hormones Features
Table 3. Monoclonal Antibodies Features
Table 4. Insulin Features
Table 5. Peptides Features
Table 6. Erythropoietin Features
Table 7. Others Features
Table 11. Global Biosimilar Market Share by Application: 2020 VS 2026
Table 12. Oncology Case Studies
Table 13. Chronic and Autoimmune Diseases Case Studies
Table 14. Growth Hormone Deficiency Case Studies
Table 15. Infectious Diseases Case Studies
Table 16. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biosimilar Report Years Considered
Table 29. Global Biosimilar Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biosimilar Market Share by Regions: 2021 VS 2026
Table 31. North America Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biosimilar Consumption by Countries (2015-2020)
Table 42. East Asia Biosimilar Consumption by Countries (2015-2020)
Table 43. Europe Biosimilar Consumption by Region (2015-2020)
Table 44. South Asia Biosimilar Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biosimilar Consumption by Countries (2015-2020)
Table 46. Middle East Biosimilar Consumption by Countries (2015-2020)
Table 47. Africa Biosimilar Consumption by Countries (2015-2020)
Table 48. Oceania Biosimilar Consumption by Countries (2015-2020)
Table 49. South America Biosimilar Consumption by Countries (2015-2020)
Table 50. Rest of the World Biosimilar Consumption by Countries (2015-2020)
Table 51. Allergan plc Biosimilar Product Specification
Table 52. Dr. Reddy’s Laboratories Biosimilar Product Specification
Table 53. BioXpress Therapeutics Biosimilar Product Specification
Table 54. BIOCAD Biosimilar Product Specification
Table 55. Coherus BioSciences Biosimilar Product Specification
Table 56. Biocon Biosimilar Product Specification
Table 57. Intas Pharmaceuticals Limited Biosimilar Product Specification
Table 58. Celltrion Biosimilar Product Specification
Table 59. Boehringer Ingelheim Biosimilar Product Specification
Table 60. Genor BioPharma Biosimilar Product Specification
Table 61. Novartis Biosimilar Product Specification
Table 62. Pfizer Biosimilar Product Specification
Table 63. Reliance Life Sciences Biosimilar Product Specification
Table 101. Global Biosimilar Production Forecast by Region (2021-2026)
Table 102. Global Biosimilar Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biosimilar Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biosimilar Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biosimilar Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biosimilar Sales Price Forecast by Type (2021-2026)
Table 107. Global Biosimilar Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biosimilar Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biosimilar Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biosimilar Consumption Forecast 2021-2026 by Country
Table 111. Europe Biosimilar Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biosimilar Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biosimilar Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biosimilar Consumption Forecast 2021-2026 by Country
Table 115. Africa Biosimilar Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biosimilar Consumption Forecast 2021-2026 by Country
Table 117. South America Biosimilar Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biosimilar Consumption Forecast 2021-2026 by Country
Table 119. Biosimilar Distributors List
Table 120. Biosimilar Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biosimilar Consumption and Growth Rate (2015-2020)
Figure 2. North America Biosimilar Consumption Market Share by Countries in 2020
Figure 3. United States Biosimilar Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biosimilar Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biosimilar Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biosimilar Consumption Market Share by Countries in 2020
Figure 8. China Biosimilar Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biosimilar Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biosimilar Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biosimilar Consumption and Growth Rate
Figure 12. Europe Biosimilar Consumption Market Share by Region in 2020
Figure 13. Germany Biosimilar Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biosimilar Consumption and Growth Rate (2015-2020)
Figure 15. France Biosimilar Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biosimilar Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biosimilar Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biosimilar Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biosimilar Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biosimilar Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biosimilar Consumption and Growth Rate
Figure 23. South Asia Biosimilar Consumption Market Share by Countries in 2020
Figure 24. India Biosimilar Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biosimilar Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biosimilar Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biosimilar Consumption and Growth Rate
Figure 28. Southeast Asia Biosimilar Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biosimilar Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biosimilar Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biosimilar Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biosimilar Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biosimilar Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biosimilar Consumption and Growth Rate
Figure 37. Middle East Biosimilar Consumption Market Share by Countries in 2020
Figure 38. Turkey Biosimilar Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biosimilar Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biosimilar Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biosimilar Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biosimilar Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biosimilar Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biosimilar Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biosimilar Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biosimilar Consumption and Growth Rate
Figure 48. Africa Biosimilar Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biosimilar Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biosimilar Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biosimilar Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biosimilar Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biosimilar Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biosimilar Consumption and Growth Rate
Figure 55. Oceania Biosimilar Consumption Market Share by Countries in 2020
Figure 56. Australia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biosimilar Consumption and Growth Rate (2015-2020)
Figure 58. South America Biosimilar Consumption and Growth Rate
Figure 59. South America Biosimilar Consumption Market Share by Countries in 2020
Figure 60. Brazil Biosimilar Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biosimilar Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biosimilar Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biosimilar Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biosimilar Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biosimilar Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biosimilar Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biosimilar Consumption and Growth Rate
Figure 69. Rest of the World Biosimilar Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biosimilar Consumption and Growth Rate (2015-2020)
Figure 71. Global Biosimilar Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biosimilar Price and Trend Forecast (2015-2026)
Figure 74. North America Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biosimilar Consumption Forecast 2021-2026
Figure 95. East Asia Biosimilar Consumption Forecast 2021-2026
Figure 96. Europe Biosimilar Consumption Forecast 2021-2026
Figure 97. South Asia Biosimilar Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biosimilar Consumption Forecast 2021-2026
Figure 99. Middle East Biosimilar Consumption Forecast 2021-2026
Figure 100. Africa Biosimilar Consumption Forecast 2021-2026
Figure 101. Oceania Biosimilar Consumption Forecast 2021-2026
Figure 102. South America Biosimilar Consumption Forecast 2021-2026
Figure 103. Rest of the world Biosimilar Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Biosimilar Market Share by Type: 2020 VS 2026
Table 2. Human Growth Hormones Features
Table 3. Monoclonal Antibodies Features
Table 4. Insulin Features
Table 5. Peptides Features
Table 6. Erythropoietin Features
Table 7. Others Features
Table 11. Global Biosimilar Market Share by Application: 2020 VS 2026
Table 12. Oncology Case Studies
Table 13. Chronic and Autoimmune Diseases Case Studies
Table 14. Growth Hormone Deficiency Case Studies
Table 15. Infectious Diseases Case Studies
Table 16. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biosimilar Report Years Considered
Table 29. Global Biosimilar Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biosimilar Market Share by Regions: 2021 VS 2026
Table 31. North America Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biosimilar Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biosimilar Consumption by Countries (2015-2020)
Table 42. East Asia Biosimilar Consumption by Countries (2015-2020)
Table 43. Europe Biosimilar Consumption by Region (2015-2020)
Table 44. South Asia Biosimilar Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biosimilar Consumption by Countries (2015-2020)
Table 46. Middle East Biosimilar Consumption by Countries (2015-2020)
Table 47. Africa Biosimilar Consumption by Countries (2015-2020)
Table 48. Oceania Biosimilar Consumption by Countries (2015-2020)
Table 49. South America Biosimilar Consumption by Countries (2015-2020)
Table 50. Rest of the World Biosimilar Consumption by Countries (2015-2020)
Table 51. Allergan plc Biosimilar Product Specification
Table 52. Dr. Reddy’s Laboratories Biosimilar Product Specification
Table 53. BioXpress Therapeutics Biosimilar Product Specification
Table 54. BIOCAD Biosimilar Product Specification
Table 55. Coherus BioSciences Biosimilar Product Specification
Table 56. Biocon Biosimilar Product Specification
Table 57. Intas Pharmaceuticals Limited Biosimilar Product Specification
Table 58. Celltrion Biosimilar Product Specification
Table 59. Boehringer Ingelheim Biosimilar Product Specification
Table 60. Genor BioPharma Biosimilar Product Specification
Table 61. Novartis Biosimilar Product Specification
Table 62. Pfizer Biosimilar Product Specification
Table 63. Reliance Life Sciences Biosimilar Product Specification
Table 101. Global Biosimilar Production Forecast by Region (2021-2026)
Table 102. Global Biosimilar Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biosimilar Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biosimilar Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biosimilar Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biosimilar Sales Price Forecast by Type (2021-2026)
Table 107. Global Biosimilar Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biosimilar Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biosimilar Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biosimilar Consumption Forecast 2021-2026 by Country
Table 111. Europe Biosimilar Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biosimilar Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biosimilar Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biosimilar Consumption Forecast 2021-2026 by Country
Table 115. Africa Biosimilar Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biosimilar Consumption Forecast 2021-2026 by Country
Table 117. South America Biosimilar Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biosimilar Consumption Forecast 2021-2026 by Country
Table 119. Biosimilar Distributors List
Table 120. Biosimilar Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biosimilar Consumption and Growth Rate (2015-2020)
Figure 2. North America Biosimilar Consumption Market Share by Countries in 2020
Figure 3. United States Biosimilar Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biosimilar Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biosimilar Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biosimilar Consumption Market Share by Countries in 2020
Figure 8. China Biosimilar Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biosimilar Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biosimilar Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biosimilar Consumption and Growth Rate
Figure 12. Europe Biosimilar Consumption Market Share by Region in 2020
Figure 13. Germany Biosimilar Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biosimilar Consumption and Growth Rate (2015-2020)
Figure 15. France Biosimilar Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biosimilar Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biosimilar Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biosimilar Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biosimilar Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biosimilar Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biosimilar Consumption and Growth Rate
Figure 23. South Asia Biosimilar Consumption Market Share by Countries in 2020
Figure 24. India Biosimilar Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biosimilar Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biosimilar Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biosimilar Consumption and Growth Rate
Figure 28. Southeast Asia Biosimilar Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biosimilar Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biosimilar Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biosimilar Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biosimilar Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biosimilar Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biosimilar Consumption and Growth Rate
Figure 37. Middle East Biosimilar Consumption Market Share by Countries in 2020
Figure 38. Turkey Biosimilar Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biosimilar Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biosimilar Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biosimilar Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biosimilar Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biosimilar Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biosimilar Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biosimilar Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biosimilar Consumption and Growth Rate
Figure 48. Africa Biosimilar Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biosimilar Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biosimilar Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biosimilar Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biosimilar Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biosimilar Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biosimilar Consumption and Growth Rate
Figure 55. Oceania Biosimilar Consumption Market Share by Countries in 2020
Figure 56. Australia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biosimilar Consumption and Growth Rate (2015-2020)
Figure 58. South America Biosimilar Consumption and Growth Rate
Figure 59. South America Biosimilar Consumption Market Share by Countries in 2020
Figure 60. Brazil Biosimilar Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biosimilar Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biosimilar Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biosimilar Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biosimilar Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biosimilar Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biosimilar Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biosimilar Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biosimilar Consumption and Growth Rate
Figure 69. Rest of the World Biosimilar Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biosimilar Consumption and Growth Rate (2015-2020)
Figure 71. Global Biosimilar Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biosimilar Price and Trend Forecast (2015-2026)
Figure 74. North America Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biosimilar Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biosimilar Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biosimilar Consumption Forecast 2021-2026
Figure 95. East Asia Biosimilar Consumption Forecast 2021-2026
Figure 96. Europe Biosimilar Consumption Forecast 2021-2026
Figure 97. South Asia Biosimilar Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biosimilar Consumption Forecast 2021-2026
Figure 99. Middle East Biosimilar Consumption Forecast 2021-2026
Figure 100. Africa Biosimilar Consumption Forecast 2021-2026
Figure 101. Oceania Biosimilar Consumption Forecast 2021-2026
Figure 102. South America Biosimilar Consumption Forecast 2021-2026
Figure 103. Rest of the world Biosimilar Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
